The three Sopharma AD factories - the one in Kazanlak, the Tablet production and Ampoule production in Sofia - have Nivalin in common, one of the strongest Sopharma products. Nivalin is sold in more than 10 countries outside Bulgaria, making it one of the most famous Sopharma products. It increases the intensity of the reflex centers of the spinal cord, medulla oblongata and cerebral cortex, thus influences all links of the reflex arc.
Sofia, Bulgaria, July 10, 2025 – In accordance with the requirements of Art.
Sofia, Bulgaria, July 3, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 2, 2025 the Company sold 518 619 (five hundred eighteen thousand six hundred and eighteen) repurchased own shares representing 0.29% of the share capital of the Company, at a total value of BGN 3 640 994.86 on the Bulgarian Stock Exchange, the average price per share was BGN 7.02.
Sofia, Bulgaria, July 2, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 1, 2025 the Company sold 500 (five hundred) repurchased own shares representing 0.0003% of the share capital of the Company, at a total value of BGN 3 600.00 on the Bulgarian Stock Exchange, the average price per share was BGN 7.20.
Sofia, Bulgaria, June 30, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 27, 2025 the Company sold 6 000 (six thousand) repurchased own shares representing 0.003% of the share capital of the Company, at a total value of BGN 39 760.00 on the Bulgarian Stock Exchange, the average price per share was BGN 6.63.
